Lista de obras -

(89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

artículo científico publicado en 2009

690: ALL-CAUSE MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT'S RELATED NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS.

scientific article published in 2022

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

artículo científico publicado en 2010

89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

artículo científico publicado en 2014

A novel cryoballoon ablation system for eradication of dysplastic Barrett's esophagus: a first-in-human feasibility study

scientific article published on 11 November 2019

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

artículo científico

A standardized light-emitting diode device for photoimmunotherapy

artículo científico publicado en 2014

Back-table fluorescence-guided imaging for circumferential resection margin evaluation in locally advanced rectal cancer patients using bevacizumab-800CW

scientific article published on 18 October 2019

C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies

scientific article published on 06 April 2020

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

artículo científico publicado en 2012

Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer.

artículo científico publicado en 2017

Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use

artículo científico publicado en 2016

Endoscopic full-thickness resection (eFTR) of colorectal lesions: results from the Dutch colorectal eFTR registry

scientific article published on 04 June 2020

Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies

artículo científico publicado en 2020

Feasibility of vascular endothelial growth factor imaging in human atherosclerotic plaque using (89)Zr-bevacizumab positron emission tomography

artículo científico publicado en 2013

Fluorescence-guided visualization of soft tissue sarcomas by targeting vascular endothelial growth factor-A: a phase 1 single-center clinical trial

artículo científico publicado en 2020

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.

artículo científico publicado en 2017

Image-guided in situ detection of bacterial biofilms in a human prosthetic knee infection model: a feasibility study for clinical diagnosis of prosthetic joint infections

artículo científico publicado en 2020

Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

scientific article published in Nature Communications

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

artículo científico publicado en 2007

In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.

artículo científico publicado en 2014

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies

artículo científico publicado en 2011

Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period

artículo científico publicado en 2021

Mo1200 FEASIBILITY, SAFETY, TOLERABILITY AND DOSE-RELATED EFFICACY OF A NOVEL CRYOBALLOON SWIPE ABLATION (CBSAS90) DEVICE IN DYSPLASTIC BARRETT'S ESOPHAGUS

scholarly article

Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection

artículo científico publicado en 2015

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study

artículo científico publicado en 2016

More on bevacizumab in hereditary hemorrhagic telangiectasia

artículo científico publicado en 2009

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets

artículo científico publicado en 2010

Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A.

artículo científico publicado en 2017

Novel developments in endoscopic mucosal imaging.

artículo científico publicado en 2018

Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy.

artículo científico publicado en 2018

Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer

scientific article published on 18 September 2019

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW

scientific article published on 10 January 2019

Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes

artículo científico publicado en 2004

The Failing Heart Stimulates Tumor Growth by Circulating Factors.

artículo científico publicado en 2018

The optimal imaging window for dysplastic colorectal polyp detection using c-Met targeted fluorescence molecular endoscopy

artículo científico publicado en 2020

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

artículo científico publicado en 2016

Total abdominal 18F-FDG uptake reflects intestinal adenoma burden in Apc mutant mice.

artículo científico publicado en 2011

Toward molecular imaging-driven drug development in oncology

artículo científico publicado en 2011

Towards clinically translatable NIR fluorescence molecular guidance for colonoscopy

artículo científico publicado en 2013

Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial

artículo científico publicado en 2020

Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

artículo científico publicado en 2016

Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines

artículo científico publicado en 2017

VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment.

artículo científico publicado en 2010

VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.

artículo científico publicado en 2011

Lista de obras de

(89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

690: ALL-CAUSE MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT'S RELATED NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS.

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

A novel cryoballoon ablation system for eradication of dysplastic Barrett's esophagus: a first-in-human feasibility study

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

A standardized light-emitting diode device for photoimmunotherapy

Back-table fluorescence-guided imaging for circumferential resection margin evaluation in locally advanced rectal cancer patients using bevacizumab-800CW

C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy

Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer.

Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use

Endoscopic full-thickness resection (eFTR) of colorectal lesions: results from the Dutch colorectal eFTR registry

Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies

Feasibility of vascular endothelial growth factor imaging in human atherosclerotic plaque using (89)Zr-bevacizumab positron emission tomography

Fluorescence-guided visualization of soft tissue sarcomas by targeting vascular endothelial growth factor-A: a phase 1 single-center clinical trial

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.

Image-guided in situ detection of bacterial biofilms in a human prosthetic knee infection model: a feasibility study for clinical diagnosis of prosthetic joint infections

Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies

Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period

Mo1200 FEASIBILITY, SAFETY, TOLERABILITY AND DOSE-RELATED EFFICACY OF A NOVEL CRYOBALLOON SWIPE ABLATION (CBSAS90) DEVICE IN DYSPLASTIC BARRETT'S ESOPHAGUS

Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study

More on bevacizumab in hereditary hemorrhagic telangiectasia

Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets

Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A.

Novel developments in endoscopic mucosal imaging.

Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy.

Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW

Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes

The Failing Heart Stimulates Tumor Growth by Circulating Factors.

The optimal imaging window for dysplastic colorectal polyp detection using c-Met targeted fluorescence molecular endoscopy

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

Total abdominal 18F-FDG uptake reflects intestinal adenoma burden in Apc mutant mice.

Toward molecular imaging-driven drug development in oncology

Towards clinically translatable NIR fluorescence molecular guidance for colonoscopy

Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): study protocol of a European multicenter randomised controlled trial

Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines

VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment.

VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.